Edny Inui

About Edny Inui

I am a neuroscientist and venture investor with over 20 years of experience spanning research, business development, and venture capital. Today, I serve as a Partner at Palo Santo, a $50M fund dedicated to advancing psychedelic and novel CNS target therapeutics that address unmet needs in mental health and brain disorders.My career began at the research bench, where my PhD work at the University of Michigan explored the role of fibroblast growth factors in depression and circadian biology. After earning my MBA from the University of Chicago, I transitioned into biotech strategy and business development, helping to build and scale organizations at the cutting edge of science. I’ve led partnerships and growth initiatives at companies including Calico Life Sciences (AbbVie/Google aging moonshot), Caribou Biosciences (CRISPR gene editing for CAR-T), and Acadia Pharmaceuticals (Neuropsych and rare disease).In venture, I draw on this dual background: scientific depth and business-building experience to identify, support, and accelerate transformative companies. I serve on boards and as an observer to multiple biotech startups, and I am passionate about enabling visionary founders to bring next-generation neuroscience and psychedelic therapeutics to patients in need.I believe the future of mental health depends on translating bold science into scalable, accessible therapies!

Experience

1. Board Observer

   Gilgamesh Pharma

   Apr 2025 — Present

Education

• The University of Chicago Booth School of Business

  Master of Business Administration - MBA

• Massachusetts Institute of Technology

  BS, Biology

• University of Michigan

  PhD, Neuroscience

• New Bedford High School

  High School